Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-05-04 @ 1:09 AM
Study NCT ID:
NCT05010005
Status:
RECRUITING
Last Update Posted:
2025-12-03
First Post:
2021-08-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Ruxolitinib and Duvelisib in People With Lymphoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
21-176
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None